Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Dodel

Showing results (191-200 of 250) with videos related to

Pageof 25
Sort By:
Pharmacoeconomics|August 16, 2005
Cost of illness and its predictors for Parkinson's disease in GermanyAnnika E Spottke, Martin Reuter, Olaf Machat, et al.
Journal of Neurology|April 13, 2010
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophyYaroslav Winter, Karsten Schepelmann, Annika E Spottke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 18, 2013
Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's diseaseRichard Dodel, Bengt Jönsson, Jens Peter Reese, et al.
Annals of Neurology|September 5, 2002
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's diseaseRichard Dodel, Harald Hampel, Candan Depboylu, et al.
European Journal of Neurology|February 14, 2026
Epidemiology and Economic Burden of Sleep Disorders in EuropeClaudio L A Bassetti, Luisa S Welter, Mateo Montes-Martinez, et al.
Human Brain Mapping|December 3, 2019
Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?Martin Gorges, Martin S Kunz, Hans-Peter Müller, et al.
BMC Geriatrics|April 16, 2024
Which Comprehensive Geriatric Assessment (CGA) instruments are currently used in Germany: a surveyJennifer Kudelka, Malte Ollenschläger, Richard Dodel, et al.
Journal of Parkinson'S Disease|July 4, 2017
A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes MeasurementPaul de Roos, Bastiaan R Bloem, Thomas A Kelley, et al.
European Journal of Neurology|February 4, 2021
Status of clinical research in neurology in Germany-A national surveyLisa Lohmann, Anna Lammerskitten, Melanie Korsen, et al.
Parkinsonism & Related Disorders|December 15, 2015
TREM2 rare variant p.R47H is not associated with Parkinson's diseaseDavid Mengel, Mathias Thelen, Monika Balzer-Geldsetzer, et al.
Pageof 25

Showing results (191-200 of 250) with videos related to

Sort By:
Pageof 25
Pharmacoeconomics|August 16, 2005
Cost of illness and its predictors for Parkinson's disease in GermanyAnnika E Spottke, Martin Reuter, Olaf Machat, et al.
Journal of Neurology|April 13, 2010
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophyYaroslav Winter, Karsten Schepelmann, Annika E Spottke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 18, 2013
Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's diseaseRichard Dodel, Bengt Jönsson, Jens Peter Reese, et al.
Annals of Neurology|September 5, 2002
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's diseaseRichard Dodel, Harald Hampel, Candan Depboylu, et al.
European Journal of Neurology|February 14, 2026
Epidemiology and Economic Burden of Sleep Disorders in EuropeClaudio L A Bassetti, Luisa S Welter, Mateo Montes-Martinez, et al.
Human Brain Mapping|December 3, 2019
Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?Martin Gorges, Martin S Kunz, Hans-Peter Müller, et al.
BMC Geriatrics|April 16, 2024
Which Comprehensive Geriatric Assessment (CGA) instruments are currently used in Germany: a surveyJennifer Kudelka, Malte Ollenschläger, Richard Dodel, et al.
Journal of Parkinson'S Disease|July 4, 2017
A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes MeasurementPaul de Roos, Bastiaan R Bloem, Thomas A Kelley, et al.
European Journal of Neurology|February 4, 2021
Status of clinical research in neurology in Germany-A national surveyLisa Lohmann, Anna Lammerskitten, Melanie Korsen, et al.
Parkinsonism & Related Disorders|December 15, 2015
TREM2 rare variant p.R47H is not associated with Parkinson's diseaseDavid Mengel, Mathias Thelen, Monika Balzer-Geldsetzer, et al.
Pageof 25